Sarcopenia and Myosteatosis Predict Adverse Outcomes After Emergency Laparotomy: A Multi-center Observational Cohort Study.

Samantha Body, Marjolein A P Ligthart, Saqib Rahman, James Ward, Peter May-Miller, Philip H Pucher, Nathan J Curtis, Malcolm A West

Journal: Annals of surgery 2022;275(6):1103-1111

PMID: 33914486

Abstract

OBJECTIVE

To determine the relationship between BC, specifically low skeletal muscle mass (sarcopenia) and poor muscle quality (myosteatosis) and outcomes in emergency laparotomy patients.

BACKGROUND

Emergency laparotomy has one of the highest morbidity and mortality rates of all surgical interventions. BC objectively identifies patients at risk of adverse outcomes in elective cancer cohorts, however, evidence is lacking in emergency surgery.

METHODS

An observational cohort study of patients undergoing emergency laparotomy at ten English hospitals was performed. BC analyses were performed at the third lumbar vertebrae level using preoperative computed tomography images to quantify skeletal muscle index (SMI) and skeletal muscle radiation attenuation (SM-RA). Sex-specific SMI and SM-RA were determined, with the lower tertile splits defining sarcopenia (low SMI) and myosteatosis (low SM-RA). Accuracy of mortality risk prediction, incorporating SMI and SM-RA variables into risk models was assessed with regression modeling.

RESULTS

Six hundred ten patients were included. Sarcopenia and myosteatosis were both associated with increased risk of morbidity (52.1% vs 45.1%, P = 0.028; 57.5% vs 42.6%, P = 0.014), 30-day (9.5% vs 3.6%, P = 0.010; 14.9% vs 3.4%, P < 0.001), and 1-year mortality (27.4% vs 11.5%, P < 0.001; 29.7% vs 12.5%, P < 0.001). Risk-adjusted 30-day mortality was significantly increased by sarcopenia [OR 2.56 (95% CI 1.12-5.84), P = 0.026] and myosteatosis [OR 4.26 (2.01-9.06), P < 0.001], similarly at 1-year [OR 2.66 (95% CI 1.57-4.52), P < 0.001; OR2.08 (95%CI 1.26-3.41), P = 0.004]. BC data increased discrimination of an existing mortality risk-prediction model (AUC 0.838, 95% CI 0.835-0.84).

CONCLUSION

Sarcopenia and myosteatosis are associated with increased adverse outcomes in emergency laparotomy patients.

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.

Address: Salisbury NHS Foundation Trust, Salisbury, UK.; Department of Surgery, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.; Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands.; University Hospitals Southampton NHS Foundation Trust, Southampton, UK.; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Department of Surgery, Queen Alexandra Hospital, University Hospital Portsmouth NHS Trust, Portsmouth, UK.; Department of Surgery and Cancer, Imperial College London, London, UK.; Anaesthesia and Critical Care Research Area, NIHR Biomedical Research Center, University of Southampton, Southampton, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.